In Brief: Pharmakon Labs
This article was originally published in The Tan Sheet
Executive Summary
Pharmakon Labs: Orasept oral anesthetic, antiseptic and astringent contains tannic acid, which is not GRAS/E as a cold sore and fever blister treatment ingredient, rendering the product mislabeled, FDA told the firm in a recent warning letter. However, "even without the presence of tannic acid in the formulation for Orasept, the product is a `new drug' because of claims for gingivitis and herpes simplex cold sores found in the labeling" and is misbranded because it fails to bear adequate directions for use, the agency notes...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: